TY - JOUR AU - Torre, L. A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Conway, E. M. PY - 2016 DA - 2016// TI - Macrophages, inflammation, and lung Cancer JO - Am J Respir Crit Care Med VL - 193 UR - https://doi.org/10.1164/rccm.201508-1545CI DO - 10.1164/rccm.201508-1545CI ID - Conway2016 ER - TY - JOUR AU - Doebele, R. C. PY - 2012 DA - 2012// TI - Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2906 DO - 10.1158/1078-0432.CCR-11-2906 ID - Doebele2012 ER - TY - STD TI - Noone AM, et al. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1975-2015. https://seer.cancer.gov/csr/1975_2015/. UR - https://seer.cancer.gov/csr/1975_2015/ ID - ref4 ER - TY - JOUR AU - Korniluk, A. PY - 2017 DA - 2017// TI - From inflammation to cancer JO - Ir J Med Sci VL - 186 UR - https://doi.org/10.1007/s11845-016-1464-0 DO - 10.1007/s11845-016-1464-0 ID - Korniluk2017 ER - TY - JOUR AU - Candido, J. AU - Hagemann, T. PY - 2013 DA - 2013// TI - Cancer-related inflammation JO - J Clin Immunol VL - 33 UR - https://doi.org/10.1007/s10875-012-9847-0 DO - 10.1007/s10875-012-9847-0 ID - Candido2013 ER - TY - JOUR AU - Singh, Y. PY - 2017 DA - 2017// TI - Targeting tumor associated macrophages (TAMs) via nanocarriers JO - J Control Release VL - 254 UR - https://doi.org/10.1016/j.jconrel.2017.03.395 DO - 10.1016/j.jconrel.2017.03.395 ID - Singh2017 ER - TY - JOUR AU - Mei, J. PY - 2016 DA - 2016// TI - Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: a systemic review and meta-analysis JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.9079 DO - 10.18632/oncotarget.9079 ID - Mei2016 ER - TY - JOUR AU - Zhao, X. PY - 2017 DA - 2017// TI - Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature JO - Oncotarget VL - 8 ID - Zhao2017 ER - TY - JOUR AU - Fritz, J. M. PY - 2014 DA - 2014// TI - Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas JO - Front Immunol VL - 5 UR - https://doi.org/10.3389/fimmu.2014.00587 DO - 10.3389/fimmu.2014.00587 ID - Fritz2014 ER - TY - STD TI - Hsiao WL, Liu L. The role of traditional Chinese herbal medicines in cancer therapy--from TCM theory to mechanistic insights. Planta Med. 2010;76(11):1118–31. ID - ref11 ER - TY - JOUR AU - Ling, C. AU - Yue, X. AU - Ling, C. PY - 2014 DA - 2014// TI - Three advantages of using traditional Chinese medicine to prevent and treat tumor JO - J Integr Med VL - 12 UR - https://doi.org/10.1016/S2095-4964(14)60038-8 DO - 10.1016/S2095-4964(14)60038-8 ID - Ling2014 ER - TY - JOUR AU - Xu, J. PY - 2016 DA - 2016// TI - Synergistic effect and molecular mechanisms of traditional Chinese medicine on regulating tumor microenvironment and Cancer cells JO - Biomed Res Int VL - 2016 ID - Xu2016 ER - TY - JOUR AU - Zhou, W. AU - Chen, Y. AU - Zhang, X. PY - 2017 DA - 2017// TI - Astragaloside IV alleviates lipopolysaccharide-induced acute kidney injury through down-regulating cytokines, CCR5 and p-ERK, and elevating anti-oxidative ability JO - Med Sci Monit VL - 23 UR - https://doi.org/10.12659/MSM.899618 DO - 10.12659/MSM.899618 ID - Zhou2017 ER - TY - JOUR AU - Cai, Z. PY - 2016 DA - 2016// TI - Astragaloside IV ameliorates necrotizing enterocolitis by attenuating oxidative stress and suppressing inflammation via the vitamin D3-upregulated protein 1/NF-κB signaling pathway JO - Exp Ther Med VL - 12 UR - https://doi.org/10.3892/etm.2016.3629 DO - 10.3892/etm.2016.3629 ID - Cai2016 ER - TY - JOUR AU - WANG, P. P. PY - 2014 DA - 2014// TI - Astragaloside IV reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines JO - Mol Med Rep VL - 9 UR - https://doi.org/10.3892/mmr.2014.2074 DO - 10.3892/mmr.2014.2074 ID - WANG2014 ER - TY - JOUR AU - Komohara, Y. PY - 2016 DA - 2016// TI - Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy JO - Adv Drug Deliv Rev VL - 99 UR - https://doi.org/10.1016/j.addr.2015.11.009 DO - 10.1016/j.addr.2015.11.009 ID - Komohara2016 ER - TY - JOUR AU - Genin, M. PY - 2015 DA - 2015// TI - M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1546-9 DO - 10.1186/s12885-015-1546-9 ID - Genin2015 ER - TY - JOUR AU - Chen, Y. PY - 2017 DA - 2017// TI - Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0408-0 DO - 10.1186/s13045-017-0408-0 ID - Chen2017 ER - TY - JOUR AU - Kimura, Y. N. PY - 2007 DA - 2007// TI - Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis JO - Cancer Sci VL - 98 UR - https://doi.org/10.1111/j.1349-7006.2007.00633.x DO - 10.1111/j.1349-7006.2007.00633.x ID - Kimura2007 ER - TY - JOUR AU - Ostuni, R. PY - 2015 DA - 2015// TI - Macrophages and cancer: from mechanisms to therapeutic implications JO - Trends Immunol VL - 36 UR - https://doi.org/10.1016/j.it.2015.02.004 DO - 10.1016/j.it.2015.02.004 ID - Ostuni2015 ER - TY - JOUR AU - Sica, A. PY - 2006 DA - 2006// TI - Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy JO - Eur J Cancer VL - 42 UR - https://doi.org/10.1016/j.ejca.2006.01.003 DO - 10.1016/j.ejca.2006.01.003 ID - Sica2006 ER - TY - JOUR AU - Qian, B. Z. AU - Pollard, J. W. PY - 2010 DA - 2010// TI - Macrophage diversity enhances tumor progression and metastasis JO - Cell VL - 141 UR - https://doi.org/10.1016/j.cell.2010.03.014 DO - 10.1016/j.cell.2010.03.014 ID - Qian2010 ER - TY - JOUR AU - Du, Q. PY - 2008 DA - 2008// TI - Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma JO - Can J Physiol Pharmacol VL - 86 UR - https://doi.org/10.1139/Y08-053 DO - 10.1139/Y08-053 ID - Du2008 ER - TY - JOUR AU - Tan, S. PY - 2013 DA - 2013// TI - Preventive effects of a natural anti-inflammatory agent, Astragaloside IV, on ischemic acute kidney injury in rats JO - Evid Based Complement Alternat Med VL - 2013 ID - Tan2013 ER - TY - JOUR AU - Karin, M. AU - Greten, F. R. PY - 2005 DA - 2005// TI - NF-kappaB: linking inflammation and immunity to cancer development and progression JO - Nat Rev Immunol VL - 5 UR - https://doi.org/10.1038/nri1703 DO - 10.1038/nri1703 ID - Karin2005 ER - TY - JOUR AU - Murray, P. J. PY - 2017 DA - 2017// TI - Macrophage Polarization JO - Annu Rev Physiol VL - 79 UR - https://doi.org/10.1146/annurev-physiol-022516-034339 DO - 10.1146/annurev-physiol-022516-034339 ID - Murray2017 ER - TY - JOUR AU - Zhang, Y. PY - 2013 DA - 2013// TI - ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages JO - Cell Res VL - 23 UR - https://doi.org/10.1038/cr.2013.75 DO - 10.1038/cr.2013.75 ID - Zhang2013 ER - TY - JOUR AU - Qi, W. PY - 2014 DA - 2014// TI - Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells JO - Cell Stress Chaperones VL - 19 UR - https://doi.org/10.1007/s12192-013-0438-7 DO - 10.1007/s12192-013-0438-7 ID - Qi2014 ER - TY - JOUR AU - Russo, M. AU - Giavazzi, R. PY - 2018 DA - 2018// TI - Anti-angiogenesis for cancer: current status and prospects JO - Thromb Res VL - 164 UR - https://doi.org/10.1016/j.thromres.2018.01.030 DO - 10.1016/j.thromres.2018.01.030 ID - Russo2018 ER - TY - JOUR AU - Squadrito, M. L. AU - De Palma, M. PY - 2011 DA - 2011// TI - Macrophage regulation of tumor angiogenesis: implications for cancer therapy JO - Mol Asp Med VL - 32 UR - https://doi.org/10.1016/j.mam.2011.04.005 DO - 10.1016/j.mam.2011.04.005 ID - Squadrito2011 ER - TY - JOUR AU - Long, Y. C. AU - Zierath, J. R. PY - 2006 DA - 2006// TI - AMP-activated protein kinase signaling in metabolic regulation JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI29044 DO - 10.1172/JCI29044 ID - Long2006 ER - TY - JOUR AU - Jarzyna, R. PY - 2006 DA - 2006// TI - AMP-activated protein kinase--the key role in metabolic regulation JO - Postepy Biochem VL - 52 ID - Jarzyna2006 ER - TY - JOUR AU - Yi, C. PY - 2011 DA - 2011// TI - Resveratrol activates AMPK and suppresses LPS-induced NF-κB-dependent COX-2 activation in RAW 264.7 macrophage cells JO - Anat Cell Biol VL - 44 UR - https://doi.org/10.5115/acb.2011.44.3.194 DO - 10.5115/acb.2011.44.3.194 ID - Yi2011 ER - TY - JOUR AU - Kopsiaftis, S. AU - Hegde, P. AU - Taylor, J. R. AU - Claffey, K. P. PY - 2016 DA - 2016// TI - AMPK alpha is suppressed in bladder cancer through macrophage-mediated mechanisms JO - Transl Oncol VL - 9 UR - https://doi.org/10.1016/j.tranon.2016.07.007 DO - 10.1016/j.tranon.2016.07.007 ID - Kopsiaftis2016 ER - TY - JOUR AU - Sag, D. PY - 2008 DA - 2008// TI - Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.12.8633 DO - 10.4049/jimmunol.181.12.8633 ID - Sag2008 ER - TY - JOUR AU - Zhu, Y. P. PY - 2015 DA - 2015// TI - Adenosine 5′-monophosphate–activated protein kinase regulates IL-10–mediated anti-inflammatory signaling pathways in macrophages JO - J Immunol VL - 194 UR - https://doi.org/10.4049/jimmunol.1401024 DO - 10.4049/jimmunol.1401024 ID - Zhu2015 ER -